Nagpur
+919405117673
+919405117673

Vincristine 1mg Injection Exporter from India | Global Supply by Cordium Pharmaceuticals Pvt Ltd

Cordium Pharmaceuticals Pvt Ltd is a trusted global exporter and supplier of Vincristine 1mg Injection, delivering high-quality oncology-grade pharmaceutical products from India to international markets including the United States, United Kingdom, Germany, Netherlands, United Arab Emirates (UAE), South Africa, and Brazil with reliable and fast export support. 💉 About Vincristine 1mg Injection Vincristine is an anti-cancer (chemotherapy) medication belonging to the vinca alkaloid class. It is widely used in oncology treatment protocols under strict medical supervision. 📌 Medical Usage Vincristine 1mg Injection is commonly used in the treatment of: Acute lymphoblastic leukemia (ALL) Hodgkin’s and Non-Hodgkin’s lymphoma Pediatric cancers (as part of combination therapy) Solid tumors (as prescribed in oncology protocols) ⚠️ Dosage Information Dosage is strictly determined by an oncologist Administered via intravenous (IV) injection only Dose varies based on body surface area, cancer type, and treatment protocol Should only be given in hospital or clinical settings by trained healthcare professionals ⚠️ Side Effects Possible side effects may include: Nerve damage (peripheral neuropathy) Constipation or gastrointestinal discomfort Hair loss (temporary alopecia) Fatigue and weakness Reduced blood cell counts Injection site irritation (rare) Medical supervision is essential during therapy to monitor and manage adverse effects. 🌍 Global Export & Supply Cordium Pharmaceuticals Pvt Ltd ensures: WHO-GMP certified quality standards Secure pharmaceutical packaging Fast global export logistics Bulk & hospital supply support Compliance with international pharma regulations 📦 Export Destinations Fast delivery available to: USA | Germany | United Kingdom | Netherlands | South Africa | United Arab Emirates | Brazil 📞 Contact for Orders & Export Inquiry 📱 WhatsApp: +91-9405117673 📧 Email: info@cordiumpharma.com
 2026-04-18T13:14:50

Keywords